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Population aging is likely increasing the number of surgically treated very old (≥ 80–year‑old) 
intracranial meningioma (IM) patients. Since there is little data on mortality in this patient group, we 
studied whether survival of surgically treated very old IM patients differs from survival of a matched 
general population. We retrospectively identified 83 consecutive very old IM patients (median age 
83 years; 69% women) operated between 2010 and 2018. During the first postoperative year, operated 
IM patients suffered 2.5 times higher mortality as compared to age‑ and sex‑matched general 
population but no annual survival difference occurred thereafter. Regarding cumulative estimates, 
no excess mortality was detected after the second postoperative year. Of the patient who were and 
who were not able to live at home preoperatively, 78% and 42% lived at home within 3 months, 
respectively. Preoperative loss of capability to live at home associated with a less frequent return to 
home [odds ratio (95% confidence interval) 0.21 (0.06–0.67)]. Operated very old IM patients had short‑
term excess mortality but similar cumulative survival as the matched general population. Moreover, 
most patients returned home soon after surgery.
The number of very old (≥ 80-year-old) yet independent intracranial meningioma (IM) patients is constantly 
increasing as populations  age1. However, tumor-related symptoms, such as motor deficits, seizures and impaired 
cognition, may quickly end an independent life and perhaps even life in general in this fragile patient  group2. 
A very old age increases the risk of adverse surgical outcome, but carefully selected IM patients can sustain or 
even improve their functional status following the  surgery3–8. Nevertheless, data on the surgical outcome of very 
old IM patients is  limited9, and no studies to date have addressed excess mortality or home return after surgery 
in this patient group.
We retrospectively studied surgical outcomes of very old IM patients who were operated in a high-volume 
university hospital. We focused particularly on postoperative excess mortality and on postoperative capability 
to live at home (CLH). Our primary hypothesis was that very old IM patients suffer from postoperative excess 
mortality in comparison to the matched general population. The secondary hypothesis was that preoperatively 
dependent very old IM patients do not recover their independence and return to home after surgery. In other 
words, we hypothesized that major cranial surgery is a high-risk procedure in very old IM patients, and thus 
unlikely to be associated with favorable outcome.
Methods
Ethical considerations. The local institutional review board of Helsinki University Hospital (HUH) 
approved the data extraction from the electronic medical record systems of the study hospital, and granted a 
waiver of consent for this retrospective chart review study. The study followed the STROBE (Strengthening 
the Reporting of Observational Studies in Epidemiology) checklist and ethical principles of the Declaration of 
 Helsinki10.
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Study hospital. All included patients were operated by one of the twelve neurosurgeons of the Department 
of Neurosurgery, HUH. HUH has a catchment area of approximately 2.2 million inhabitants, and performs more 
than 90,000 surgeries every year. The Department of Neurosurgery, which is the largest neurosurgical unit in 
Finland, performs nearly 4000 annual operations. All five Finnish university hospitals are publicly funded non-
profit organizations that provide tertiary health care services for Finnish inhabitants.
Patient identification. The study cohort has been described  previously8,11,12. By utilizing a hospital-based 
electronic Centricity™ Opera (GE Healthcare) software, which is an operating theatre management solution, we 
identified all very old (≥ 80-year-old) patients who underwent their first-ever elective IM surgery at HUH. The 
register has been in use since mid-2009, hence we included patients who were operated on between January 1, 
2010 and December 31, 2018. To identify all eligible meningioma patients, we manually reviewed the medical 
notes of the identified patients through the electronic medical record (EMR) system (Uranus™, CGI). All patients 
with non-meningeal tumors or previous IM operations were excluded.
Risk scales. We used the previously validated Helsinki version of the American Society of Anesthesiologist 
(Helsinki ASA) scale to assess operative risks of included  patients13. The Helsinki ASA score has been designed 
to provide preoperative stratification specifically for elective craniotomy  patients13, and has been in clinical use 
in the Neurosurgical Department of HUH since the mid 1990s. In addition, based on medical notes in the EMR 
system, we estimated preoperative Karnofsky Performance Status (KPS)14 scores for every patient.
Patient and tumor characteristics. In addition to age and sex, we collected information about preopera-
tive symptoms and surgical indications. In terms of tumor characteristics, we defined the maximum diameter, 
location, and multiplicity of IMs by using magnetic resonance images. Specifically, we measured the maximum 
diameter in three anatomical planes (coronal, sagittal and axial), and used the largest diameter (excluding the 
dural tail) to describe the size of IM. Tumors with a maximum diameter of ≤ 5 cm were considered  small9. For 
location, we used five categories: 1) convexity, 2) falx, 3) supratentorial skull-base, 4) posterior fossa, and 5) other 
 locations3–7. We also reviewed pathology reports, and recorded the WHO grade (I–III)15 of IMs. Surgery time 
(skin-to-skin in minutes) and operation code defining the extent of resection (partial/total) were extracted from 
the Centricity™ Opera for every patient.
Follow‑up. To determine the IM patients’ postoperative performance and CLH, we reviewed the medical 
records up to 1 year after surgery. In terms of survival, the nationwide patient data repository (the Population 
Register Center) provided the information of any deaths during the follow-up. The follow-up started at the time 
of surgery and ended on the  13th of September 2020 or to death, whichever came first.
Outcome measures. In addition to excess mortality, we assessed in-hospital, 30-day and 1-year mortality 
rates. From the medical notes of the EMR system, we recorded whether IM patients were capable to live at home 
(with or without home care services) preoperatively, at discharge and at 3 months after the surgery. In Finland, 
CLH is routinely recorded in the medical notes, specifically for very old patients. Moreover, we collected infor-
mation about the length of hospitalization (days), as well as about postoperative complications. Due to the ret-
rospective design, we focused on major  complications16, which are more reliably reported in the medical notes. 
We evaluated performance status changes by estimating the KPS scores from the medical notes preoperatively, 
at discharge and in the last follow-up visit within the first postoperative year.
Statistical analyses. For excess mortality calculations, we compared observed survival rates to age-, sex- 
and year-matched survival rates in the general Finnish population. We obtained this general population data from 
a public website of Statistics Finland  (https:// pxnet2. stat. fi/ PXWeb/ pxweb/ en/ StatF in/). We calculated yearly 
estimates for both year-specific and cumulative survival rates using the Ederer II survival  method17. Using a 
multiple logistic regression model, we evaluated if the previously reported risk factors for adverse  outcome3–7,18,19 
were also associated with postoperative mortality or ability to live at home after surgery in our cohort. Since the 
main objective of our multivariable analyses was to identify factors that may associate with (not cause) adverse 
outcome in this fragile patient cohort, we adjusted the multivariable models using the significant factors found 
in univariable  models20. In the regression analyses, we dichotomized categorical variables, such as Helsinki ASA 
scale (< 4 = mild/none or ≥ 4 significant tumor-related symptoms) and tumor location (skull base or other loca-
tion). Odds ratios (ORs) with 95% confidence intervals (CIs) described the associations when applicable. As 
post hoc analyses, we also calculated excess hazard ratios (EHRs) for age, sex and preoperative loss of CLH to 
investigate whether these factors also contribute to the observed 1-year excess mortality. As  recommended17, 
we included only categorical variables in this adjusted multivariable model, and thus dichotomized age by its 
median value. We used Stata version 16.1 (Stata Corp, College Station, TX) for all statistical analyses.
Results
Patient and tumor characteristics. Patient and tumor characteristics are described in Table 1. Between 
2010 and 2018, 83 IM patients underwent the first-ever IM surgery at the age of 80 years or older. The median 
age of operated patients was 83 years (range 80 to 96 years), and most of them (69%) were women. Prior to 
surgery, nearly half (41%) of the patients presented with significant tumor-related symptoms (Helsinki ASA 
class 4), which in turn had led to the loss of CLH in 30% of the whole cohort. Only one patient lived in a health-
care institution prior to the onset of tumor-related symptoms. The three most common surgical indications 
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that were listed in the medical records were cognitive decline/psychomotor changes, motor deficits, and visual 
impairment. In terms of tumor characteristics, IMs were located most often in the skull base (40%), and were 
small (66%). The majority were graded as 1 (73%) according to the WHO grading system, and were resected 
completely (93%). Multiple meningiomas were found in 10% of the patients (Table 1).
Complications. Over one-fourth (27%) of the operated IM patients had one or more major postopera-
tive complications. The most common major complications were an intracranial hemorrhage (causing mass 
effect and/or requiring reoperation, n = 8), new epileptic seizure (n = 5) and pneumonia (n = 5) (Supplementary 
Table 1). An increasing age was the only factor associating with a higher risk of major complications (OR 1.32 
(1.08–1.61) per each year-increase in age) (Supplementary Table 2).
Table 1.  Patient and tumor characteristics. ASA American Society of Anesthesiologist; IM intracranial 
meningioma; IQR interquartile range; KPS Karnofsky Performance Status; WHO World Health Organization.
Patient characteristic
N of cases (%) 83 (100)
Age, median (range) 83 (80–96)
Female sex, n (%) 57 (68.7)






KPS before onset of IM-related symptoms, median (IQR) 80 (70–90)
Preoperative KPS, median (IQR) 60 (40–70)
Surgical indications, n (%)
Cognitive impairment 30 (36.1)
Hemiparesis/motor deficit 18 (21.7)
Visual loss 9 (10.8)
Balance disturbance 6 (7.2)
Seizure 5 (6.0)
Asymptomatic tumor growth 5 (6.0)
Gait impairment 4 (4.8)
Aphasia 2 (2.4)
Other (headache, dermal effusion, hydrocephalus) 3 (3.7)
Missing 1 (1.2)
Surgical time (min), median (IQR) 148.8 (117.0–217.2)






IM maximum diameter, n (%)
 ≤ 5 cm 55 (66.3)
 > 5 cm 28 (33.7)




Posterior fossa 7 (8.4)
Other 3 (3.6)
Multiple meningioma, n (%) 8 (9.6)
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Mortality. Two IM patients (2%) died in the hospital; one due to a major intracranial hemorrhage (did not 
wake up after the surgery) and one due to a sudden cardiac arrest 4 days after surgery. Thirty-day and 1-year 
mortality rates were 7% and 18%, respectively. Overall, 33 (40%) out of 83 patients died during the median 
follow-up of 4 years (range 2 days to 11 years). According to the adjusted regression model, each year-increase 
in age associated with the increased risk of both 30-day (OR 1.36 (1.05–1.75)) and 1-year mortality (OR 1.91 
(1.27–2.89)). Moreover, the preoperative loss of CLH was associated with a higher 1-year mortality risk (OR 5.28 
(1.11–25.26)) (Table 2). In addition, the Helsinki ASA score of 4 and each 10-unit decrease in the preoperative 
KPS were associated with increased 30-day and 1-year mortality rates in the univariable analyses, but were not 
significant in the multivariable model (Table 2). Mortality rates were similar in men and women.
Excess mortality. As compared to the age- and sex-matched general population, very old IM patients had 
an excess mortality of 150% during the first postoperative year. However, the survival rates were similar there-
after (Fig. 1). In terms of cumulative estimates, excess mortality levelled off from the third postoperative year 
onwards (Fig. 2). During the first postoperative year, the age over the median value (83 years) was associated 
with an increased excess mortality (EHR = 7.98 (1.18–53.72)). Similarly, the preoperative loss of CLH associated 
with the increased risk of excess mortality (EHR = 10.13 (1.38–74.30)) compared to the patients who were able 
to live at home prior to surgery. There were no differences between men and women.
KPS change. At discharge, half (51%) of the patients had lower KPS values than preoperatively. However, 
the majority of operated IM patients (65%) recovered fast and reached the same or improved performance level 
during the first postoperative year (Fig. 3). When evaluating only the patients who were alive after the first year, 
53% improved and 26% sustained their performance levels (Fig. 3).
Capability to live at home (CLH). Of the 26 patients who were not capable to live at home prior to sur-
gery, 2 (8%) died in hospital, and 3 (12%) regained their independence and returned home at discharge. Of the 
patients who lived at home prior to surgery (n = 57), 37 (65%) required institutional rehabilitation after surgery 
(Fig. 4). At 3 months, 11 (42%) of the patients that lost their CLH preoperatively and 45 (79%) of the patients that 
had CLH preoperatively were living at home (Fig. 4). In the adjusted multivariable model, each year-increase in 
age (OR 0.71 (0.55–0.92)) and the preoperative loss of CLH (OR 0.20 (0.06–0.63)) were associated inversely with 
the ability to live at home after 3 months (Table 3).
Table 2.  Odds ratios (ORs) with 95% confidence intervals (95% CIs) for short-term (30-day) and 1-year 
mortalities. Multivariable model includes significant factors from univariable model and patients’ sex. ASA 
American Society of Anesthesiologist; KPS Karnofsky performance status; NA not applicable. *Due to strong 
correlation between preoperative KPS and preoperative independence, we excluded preoperative KPS from the 
multivariable model for 1-year mortality.
Variables
30-day mortality 1-year mortality
Univariable Multivariable Univariable Multivariable
Age (per each year) 1.46 (1.12–1.91) 1.36 (1.05–1.75) 1.79 (1.29–2.49) 1.91 (1.27–2.89)
Sex
Male (Reference) (Reference) (Reference) (Reference)
Female 0.43 (0.08–2.27) 0.41 (0.05–3.34) 0.63 (0.20–1.99) 0.51 (0.10–2.52)
Helsinki ASA score
2–3 (Reference) NA (Reference) (Reference)
4 8.28 (0.92–74.39) NA 3.67 (1.12–11.97) 2.25 (0.48–10.43)
Preoperative KPS (per 10-unit increase) 0.48 (0.25–0.93) 0.51 (0.24–1.06) 0.61 (0.40–0.90) NA*
Preoperative capability to live at home
Yes (Reference) NA (Reference) (Reference)
No 5.00 (0.85–29.29) NA 4.50 (1.40–14.50) 5.28 (1.11–25.26)
Tumor size (per one cm increase) 1.13 (0.64–1.99) NA 1.07 (0.73–1.57) NA
Tumor location
Other (Reference) NA (Reference) NA
Skull-base 0.74 (0.13–4.30) NA 0.71 (0.22–2.32) NA
Surgical time (per 30 min increase) 0.84 (0.56–1.27) NA 0.73 (0.53–1.01) NA
Extent of resection
Partial (Omitted) NA (Reference) NA
Total (Omitted) NA 1.11 (0.12–10.27) NA
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Discussion
In our series of 83 very old consecutively operated IM patients, we found that patients suffered from a significant 
short-term excess mortality in comparison to the matched general Finnish population. Based on the difference 
between observed (15/83) and expected (6/83) deaths in the first year, surgery led to 9 additional (2.5 times higher 
number) deaths. Most (60%) of the patients who died within the first year had lost their CLH prior to surgery 
because of the meningioma-related symptoms, so it is likely that the 1-year mortality rate of these symptomatic 
patients would have been relatively high even without surgery. Therefore, the 1-year excess mortality may be an 
overestimate, and in fact the mortality rate should be compared to age- and sex-matched meningioma patients 
who were conservatively treated. However, such a prospective trial might be unethical to conduct. Following the 
second postoperative year, the survival rate and cumulative excess mortality rates of the operated patients were 
similar to the general population. Even though the risk of death was increased for the patients who were not able 
to live at home preoperatively, almost half of these patients returned home during the first three postoperative 
months. Of the patients who were able to live at home before surgery, 75% were also able to return home within 
the first 3 months. Based on the presented results, a careful patient selection seems to lead to a fair outcome.
Increased age and the preoperative loss of CLH were associated with the inability to live at home after sur-
gery. Since increased age and the preoperative loss of CLH were relatively independent factors that were also 
associated with 1-year mortality, we conducted post hoc analyses in order to further elucidate if these two factors 
also contributed to excess mortality. Indeed, age over the median value of 83 years was associated with excess 
mortality. In addition, the patients who lost their CLH preoperatively had higher excess mortality. Given that 
the life expectancy of very old and institutionalized patients is  shortened21,22, our findings suggest that if surgical 


































Figure 2.  Cumulative survival rates of operated IM patients (black connected line) with 95% CIs (black dashed 
lines) and the age-, sex- and year-matched general Finnish population (grey solid line). Difference between solid 
lines depicts the relative survival, whereas marked values below the observed survival line (black connected line) 
describe the number of patients whose follow-up lasted at least until the yearly time point.
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treatment is considered as a reasonable option for very old IM patients, surgery should perhaps be performed 
when patients are still in good condition and physically active rather than wait until progressive symptoms cause 
major functional deterioration and immobilization. It is important to note that a long-term (i.e. several weeks) 
high-dose corticosteroid treatment may slow the symptoms down, but the treatment may be complicated by 
myopathy, particularly in elderly  patients23. We have seen a few very old IM patients with severe corticosteroid 
treatment-related myopathy, and such an adverse condition may further complicate the surgery and recovery.
Figure 3.  Comparison between pre- and postoperative performance levels (measured by KPS) at discharge and 
at the last follow-up visit within the first postoperative year.
A
B
Figure 4.  Postoperative capability to live at home (A) at  discharge and (B) at 3 months. Preoperatively 
independent patients illustrate the patient who were able to live at home before surgery whereas preoperatively 
dependent patients illustrate patients who had lost their capability to live at home preoperatively.
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Our results are in line with previous  findings13,19,24,25 that have suggested that older age is related to high 
complication and mortality rates, and dependence after IM resection or neurosurgery in general. Of note, from 
five oldest patients (age range 88–96) in our series, four suffered from major postoperative complications and 
died during the first 3 months. In addition, the fifth patient was not able to live at home after the surgery. Overall, 
over one-fourth of the patients suffered from major postoperative complications. Based on a prospective and 
comprehensive complication study, this rate is higher than the overall complication rate of cranial surgeries (27% 
vs. 18%; difference of 7 patients in our series)16, which underlines the increased risk of neurosurgery in older 
patients. On the other hand, in-hospital mortality rate among the very old IM patients was similar to the figure 
of the same prospective  cohort16 (2% vs 1%; difference of only 1 patient in our series). Therefore, we believe that 
the overall results are still rather acceptable. In addition to a selection bias, relatively short surgical skin-to-skin 
times as well as the short median hospital stay may contribute to the recovery rate and subsequently to the overall 
results. Only one of the previous  studies4 of very old IM patients reported the mean surgery time, which was 
73 min higher than in our series (249 min vs. 176 min). Similarly, only one previous  study3 reported the mean 
length of hospitalization, which was 12 days longer than ours (19 days vs. 7 days). Institutional care is known 
to be associated with increased mortality and morbidity, as well as with increased healthcare  expenses22. Of the 
58 patients discharged to institutional rehabilitation, over half (59%) returned home within three postoperative 
months, which may be related to the shorter length of hospitalization.
In addition to the current study evaluating the overall rationality of operating very old meningioma patients, 
we have previously used the same patient cohort to assess the effect of peritumoral  edema8,  size12 and surgeon’s 
 experience11 on surgical outcomes. Based on our studies, surgical removal of IMs with larger peritumoral edema 
associates with more favorable  outcome8, whereas surgical treatment of giant (diameter ≥ 5 cm) IMs entails a 
high complication  rate12. Moreover, surgical results did not depend on the surgeon’s  experience11. Besides our 
own studies, to the best of our knowledge, eight  studies3–7,18,19,26 have assessed the surgical outcomes of very old 
(80 years or older) IM patients. However, no previous study has assessed excess mortality or patients’ postop-
erative return to home. In terms of survival, short-term (within 30 days) mortality rates have varied between 0 
and 29%3–7,18,19,26, and 1-year rates between 9 and 29%3,5,6,18. The largest previous hospital-based study (n = 74) 
by Sacko et al.3 reported lower 30-day (0% vs. 7%) and 1-year mortality rates (9% vs 19%) than in our study. 
Noteworthy differences between study cohorts include the mean age, which was somewhat younger in their 
series than in ours (82 years vs. 83.3 years), and the location of the meningiomas, which were located less often 
in the skull base area in their series (16% vs 40%). Moreover, no surgeries were performed for patients older than 
90 years. In terms of preoperative functional status, the proportion of patients with KPS ≥ 60 (57%) was similar 
to ours (62%). In the second largest hospital-based study (n = 51), Konglund et al.18 also reported relatively low 
30-day (4%) and 1-year mortality rates (16%), but their operated patients were in notably better condition at 
Table 3.  Odds ratios (ORs) with 95% confidence intervals (95% CIs) for 3-month independence. 
Multivariable model includes significant factors from univariable model and patients’ sex. ASA American 
Society of Anesthesiologist; KPS Karnofsky Performance Status; NA not applicable. *Due to strong correlation 
between preoperative KPS and preoperative independence, we excluded preoperative KPS from multivariable 
model.
Variables
3-month capability to live at home, 
OR (95% CI)
Univariable Multivariable
Age (per each year) 0.73 (0.59–0.90) 0.71 (0.55–0.92)
Sex
Male (Reference) (Reference)
Female 1.47 (0.56–3.89) 1.64 (0.52–5.20)
Helsinki ASA score
2–3 (Reference) (Reference)
4 0.33 (0.13–0.84) 0.48 (0.16–1.47)
Preoperative KPS (per 10-unit increase) 1.90 (1.31–2.73) NA*
Loss of preoperative independence
No (Reference) (Reference)
Yes 0.20 (0.07–0.53) 0.20 (0.06–0.63)
Tumor size (per one cm increase) 0.99 (0.72–1.36) NA
Tumor location
Other (Reference) NA




Total 0.39 (0.04–3.53) NA
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the time of surgery (KPS ≥ 80 in 41% of their patients, compared to 14% of our patients). Moreover, they did not 
operate on patients older than 90 years.
Our study may have some strengths. First, we assessed year-specific and cumulative excess mortality rates for 
the first time, providing an accurate estimation of any survival disadvantages or benefits in very old IM patients. 
Second, we assessed—also for the first time—IM patients’ capability to return home after surgery. Given that this 
measure can be easily determined in Finland, even using a retrospective medical data, we believe it serves less 
biased information about the IM patients’ independence than for example the retrospectively estimated KPS val-
ues. In fact, we were able to determine who lived at home preoperatively and 3 months after surgery for 100% of 
the patients. Third, the reported series is the largest hospital-based series of operated very old IM patients to date.
Our study is not without limitations. Like previous studies, our study was retrospective in design, and thus 
pre- and postoperative assessments were not standardized. Therefore, we tried to use unambiguous measures 
for preoperative frailty (i.e. losing the CLH) as well as for the postoperative outcome (i.e. death and return to 
home). Moreover, as we had no information about the causes of deaths occurring after the hospital discharge, 
we could not determine if these deaths were related to surgery per se. On the other hand, we believe that future 
studies with prospective data collection methods are more suitable to evaluate the impact of a more detailed 
performance status, multiple comorbidities, minor postoperative complications and causes of death after surgery. 
As another limitation, since the survival rates of the general Finnish population are publicly available at the 
national level, we were not able to compare the observed survival rates to the region-matched survival rates of 
the general population of the HUH catchment area. In the most optimal situation, comparisons could have been 
made to conservatively treated very old IM patients with similar symptoms. However, such comparisons would 
perhaps be impractical or even unethical to conduct due to a poor prognosis of conservatively treated frail and 
very old IM patients. In fact, the reported mortality rates may overestimate the risks of surgery in comparison to 
a conservative treatment of symptomatic very old IM patients. Third, our cohort contained patients from a single, 
high-volume and academic institution, and therefore the results may have a limited external value. However, 
the results of excess mortality and return to home may serve as benchmark figures for future studies, which are 
surely needed as populations continue to age rapidly. Finally, many of the promising findings in our study may 
relate to the selection bias, i.e. patients have been carefully selected for surgery. In fact, nearly all (99%) oper-
ated patients were capable to live at home before the onset of meningioma-related symptoms, whereas 87% of 
the age-matched general population in the HUH catchment area lived at home between 2010 and 2018 (https:// 
sotka net. fi/ sotka net/ en/ index). In addition, as we had no information about patients who were conservatively 
treated, our results cannot be extrapolated to all very old IM patients. Nevertheless, one-third of the operated 
patients had a poor functional status and lost their CLH at the time of surgery. Therefore, at least some of the 
patients were rather fragile at the time of major surgery.
Conclusions
Despite short-term excess mortality, very old patients operated for IM seem to have similar long-term survival 
rates as compared to the matched general population. As most operated patients sustained or regained their 
capability to live at home, surgery of selected, symptomatic and very old IM patients may be justified. Since 
preoperative dependency seems to increase the risk of adverse outcomes, surgical treatment could perhaps be 
considered at the very time when these IM patients become symptomatic.
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